Tolerx to collaborate on first-in-class cancer antibody
December 2, 2010Research and Development Cancer, T cell, Torelx, monoclonal antibody
US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …
CME Spotlight: medical communications evolves
December 2, 2010Medical Communications CME, CME Spotlight, Continuing medical education, Eugene Pozniak
I recently attended the first meeting of the MedComms Forum in Oxford. The venue of the Natural History Museum was …
Colour management for the pharmaceutical industry
December 1, 2010Manufacturing and Production colour management, packaging, pharma printing
The development and adoption of pharmaceutical specific quality standards by the printing industry has played a vital role in the …
EMA to widen public access to documents
December 1, 2010Research and Development, Sales and Marketing EMA, European Medicines Agency, European Ombudsman, patient information, transparency
The European Medicines Agency has agreed to give greater access to documents on medicines for human and veterinary use, after …
New chief executive for Merck & Co
December 1, 2010Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough
Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
Dr Martino Picardo to lead Stevenage Bioscience Catalyst
December 1, 2010Research and Development Dr Martino Pacardo, Stevenage Bioscience Catalyst, appointment, research and development
New UK science park Stevenage Bioscience Catalyst (SBC) has appointed Dr Martino Picardo as its first chief executive. Dr Picardo …
New public health body to ‘nudge’ people on healthy living
December 1, 2010NHS reforms, Public Health England, alcohol, obesity, public health, smoking
Plans for a new organiation to oversee public health in England have been unveiled, which will ‘nudge’rather than nag people …
Change is needed, concedes NICE chief, but defends record
November 30, 2010Sales and Marketing Andrew Dillon, NHS reform, NICE, cost-effectiveness, health technology assessment, hta, value-based pricing
The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …
UK pharma welcomes government reforms
November 30, 2010Manufacturing and Production, Research and Development, Sales and Marketing ABHI, ABPI, BIA, R&D tax credits, UK pharma, patent box
The UK pharma industry has responded warmly to government plans to review how best to create optimum conditions for private …
Trio of new appointments at ApotheCom ScopeMedical
November 30, 2010Medical Communications ApotheCom ScopeMedical, Huntsworth Health, ScopeMedical, appointment, medical communications
Kent, UK-based medical education agency group ApotheCom ScopeMedical has promoted three members of staff.Pictured left to right are new project …
Penn Pharma appoints new chief executive
November 30, 2010Manufacturing and Production, Research and Development David Cooper, Penn Pharma, Richard Yarwood, appointment, manufacturing and production, research and development
Richard Yarwood has joined pharmaceutical services provider Penn Pharma as chief executive. He has more than 33 years experience in …
UK tax reforms prompt £500m manufacturing investment by GSK
November 30, 2010Manufacturing and Production GSK, GlaxoSmithKline, UK corporation tax, patent box, pharma manufacturing
A decision by the UK Government to reform the corporation tax system has been followed by a major job creation …
GlaxoSmithKline forges Russian vaccines alliance
November 30, 2010Manufacturing and Production GSK, GlaxoSmithKline, JSC Binnopharm, cervical cancer vaccine, pharma manufacturing, pneumococcal vaccine, rotavirus vaccine, vaccines
GlaxoSmithKline has announced an alliance with JSC Binnopharm focusing on the secondary manufacture of a number of the pharmaceutical giant’s …
Gerresheimer boosts capacity in prefilled glass syringes
November 30, 2010Manufacturing and Production Gerresheimer, pharma packaging, prefilled syringes
German glassware specialist Gerresheimer is planning to spend around 20 million euro upgrading its facility in Buende with a fourth …
Digital Pharma: Pfizer expands online clinic and aims for viral hit
November 29, 2010Medical Communications Digital Pharma blog, ManMOT, Pfizer, patient information
Pfizer’s digital initiative targeting men who are reluctant to visit a GP is to be extended until May next year …
Graham Cox joins Idea Pharma
November 29, 2010Sales and Marketing Graham Cox, IDEA Pharma, appointment, sales and marketing
Idea Pharma has appointed Graham Cox as a senior consultant. He joins from AstraZeneca, where he was originally a client …
Millions more OTC products recalled by J&J
November 29, 2010Manufacturing and Production Benadryl Allergy Fastmelt, J&J, JJ, Johnson & Johnson, Motrin, Rolaids, Tylenol, manufacturing compliance, recalls
Johnson & Johnson has been forced to announce yet another recall of over-the-counter medicines manufactured at its Fort Washington facility …
Pharma unprepared for personalised oncology
November 29, 2010Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine
The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …
Pfizer submits Gaucher drug to EMA
November 29, 2010Sales and Marketing Cerezyme, EMA, Gaucher disease, Genzyme, Pfizer, Protalix BioTherapeutics, Shire, Vpriv, taliglucerase alfa
Pfizer and partner Protalix BioTherapeutics have submitted a marketing application to European regulator the EMA for their Gaucher disease candidate …
Doctor’s networks – an emerging engagement channel
November 29, 2010Medical Communications, Sales and Marketing Len Starnes, PatientsLikeMe, doctors' social networks, social media, social networking
The last four years have seen an extraordinary growth in physicians’ social networks and a rapid increase in levels of …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
